The Clinical Trials Chinese Promise

Oct 16, 2018 | China, Chinese Clinical Trials, Chinese Research

China, the world’s most populous country, has the potential to become a leading research destination. As reported in The BMJ Opinion, prominent research authors articulate that attitudes toward China as research hub varies depending on point of view, ideology and position. Factors making China favorable for future investment include:

  • 20% of global population
  • Pattern of morbidity and mortality comparable to Western countries
  • Potential for large numbers of patients
  • 32 national centers for clinical medicine research
  • Collaborative innovation network of more than 2100 medical institutions in 260 cities
  • Trials cost about half as much as in the West

Significant challenges persist. They include:

  • China clinical trial experience in its infancy
  • Slow trial registration process
  • Lack of training in medical schools, hospitals and institutions
  • Slow regulatory approval processes
  • Average time delay for innovative drug 14 months (10 times larger than USA)

Overcoming challenges requires a confluence of a number of factors and forces from political to socioeconomic to cultural. It will start with a more modernized regulatory and communication system. See the remaining article for more details.

Researchers/Authors:

Liming Lu is an associate professor at the Clinical Research Center, South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.

Yuqing Zhang is an assistant professor at the Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada, and the researcher at Guang’anmen Hospital, China Academy of Chinese Medical Science, Xicheng District, Beijing, China.

Gordon Guyatt is a distinguished professor at the Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.

Chunzhi Tang is a professor and vice director at South China Research Center for Acupuncture and Moxibustion, and the dean of Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.

Nenggui Xu is a professor and director at South China Research Center for Acupuncture and Moxibustion, and the vice president of Guangzhou University of Chinese Medicine, Guangzhou, China.

0 Comments